Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to $16.8 million.

  • Macrogenics' Net Income towards Common Stockholders fell 7012.56% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.6 million, marking a year-over-year increase of 2512.45%. This contributed to the annual value of -$67.0 million for FY2024, which is 63930.23% down from last year.
  • Latest data reveals that Macrogenics reported Net Income towards Common Stockholders of $16.8 million as of Q3 2025, which was down 7012.56% from -$36.3 million recorded in Q2 2025.
  • Macrogenics' Net Income towards Common Stockholders' 5-year high stood at $56.3 million during Q3 2024, with a 5-year trough of -$66.6 million in Q1 2022.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$41.8 million (2022), whereas its average is -$32.9 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first tumbled by 258368.66% in 2021, then skyrocketed by 25860.8% in 2024.
  • Macrogenics' Net Income towards Common Stockholders (Quarter) stood at -$58.2 million in 2021, then soared by 120.58% to $12.0 million in 2022, then plummeted by 511.87% to -$49.4 million in 2023, then soared by 68.75% to -$15.4 million in 2024, then surged by 209.09% to $16.8 million in 2025.
  • Its last three reported values are $16.8 million in Q3 2025, -$36.3 million for Q2 2025, and -$42.7 million during Q1 2025.